Home > 暂无记录 暂无记录 行业新闻

行业新闻


  • Daclizumab MA1018

    Daclizumab (daclizumab high-yield process) is a humanized monoclonal antibody that binds to the α-subunit (CD25) of the interleukin-2 receptor and favorably modulates the immune environment in multiple sclerosis (MS).

    More
  • Denosumab MA1019

    Denosumab, a human monoclonal antibody against receptor activator of nuclear factor κ B ligand (RANKL), has become widely used as an anti-osteoclastic agent for osteoporosis.

    More
  • Eculizumab MA1020

    Eculizumab, a humanized anti-complement C5 monoclonal antibody for treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome, blocks the terminal complement pathway required for serum bactericidal activity (SBA).

    More
  • alirocumab MA1008

    More
  • Alemtuzumab MA1007

    More
  • Current page8, Total Pages305, Total Record1524 First Prev 678910 Next Last Goto